Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases

Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases

The use of neuromuscular blocking agents (NMBAs) is common in the intensive care unit (ICU). NMBAs have been used in critically ill patients with lung diseases to optimize mechanical ventilation, prevent spontaneous respiratory efforts, reduce the work of breathing and oxygen consumption, and avoid...

Full description

Bibliographic Details
Main Authors: Ida Giorgia Iavarone, Lou’i Al-Husinat, Jorge Luis Vélez-Páez, Chiara Robba, Pedro Leme Silva, Patricia R. M. Rocco, Denise Battaglini
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
neuromuscular blocking agents
intensive care unit
acute respiratory distress syndrome
status asthmaticus
chronic obstructive pulmonary disease
Online Access:https://www.mdpi.com/2077-0383/13/4/1182

Internet

https://www.mdpi.com/2077-0383/13/4/1182

Similar Items